YAP/TAZ at the Roots of Cancer.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cancer Cell

• Publication date

  2016-06-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ccell.2016.05.005PMID 27300434PMCID PMC6186419
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of Hippo pathway regulation

  2016influential reference
• Re: Cell Adhesion. Mechanical Strain Induces E-Cadherin-Dependent Yap1 and β-Catenin Activation to Drive Cell Cycle Entry.

  2016cited by this paper
• Tead and AP1 Coordinate Transcription and Motility.

  2016influential reference
• Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein

  2016influential reference
• Abstract LB-331: Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations

  2016cited by this paper
• Autophagy maintains stemness by preventing senescence

  2016cited by this paper
• YAP Nuclear Localization in the Absence of Cell-Cell Contact Is Mediated by a Filamentous Actin-dependent, Myosin II- and Phospho-YAP-independent Pathway during Extracellular Matrix Mechanosensing*

  2016cited by this paper
• αE-catenin inhibits a Src–YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway

  2016cited by this paper
• YAP promotes malignant progression of Lkb1-deficient lung adenocarcinoma through downstream regulation of survivin.

  2015influential reference
• Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3

  2015cited by this paper
• YAP Induces High-Grade Serous Carcinoma in Fallopian Tube Secretory Epithelial Cells

  2015cited by this paper
• Alpha-Catenins Control Cardiomyocyte Proliferation by Regulating Yap Activity

  2015influential reference
• Activation of Yes-Associated Protein in Low-Grade Meningiomas Is Regulated by Merlin, Cell Density, and Extracellular Matrix Stiffness

  2015cited by this paper
• Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis

  2015influential reference
• The YAP1 oncogene contributes to bladder cancer cell proliferation and migration by regulating the H19 long noncoding RNA.

  2015influential reference
• A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth.

  2015cited by this paper
• Yap-dependent reprogramming of Lgr5+ stem cells drives intestinal regeneration and cancer

  2015influential reference
• Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy.

  2015cited by this paper
• Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling

  2015influential reference
• Aerobic glycolysis tunes YAP/TAZ transcriptional activity

  2015cited by this paper
• Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP

  2015influential reference
• Targeting YAP-dependent MDSC infiltration impairs tumor progression

  2015influential reference
• Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity

  2015cited by this paper
• A basal-like breast cancer-specific role for SRF–IL6 in YAP-induced cancer stemness

  2015cited by this paper
• Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth

  2015influential reference
• YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression.

  2015cited by this paper
• The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer

  2015influential reference
• The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer

  2015cited by this paper
• Differential control of Yorkie activity by LKB1/AMPK and the Hippo/Warts cascade in the central nervous system

  2015influential reference
• YAP Enhances Autophagic Flux to Promote Breast Cancer Cell Survival in Response to Nutrient Deprivation

  2015cited by this paper
• Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation

  2015cited by this paper
• YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers.

  2015influential reference
• A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma

  2015cited by this paper
• The Hippo Pathway Effector YAP Regulates Motility, Invasion, and Castration-Resistant Growth of Prostate Cancer Cells

  2015influential reference
• Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas

  2015cited by this paper
• Mechanical strain induces E-cadherin–dependent Yap1 and β-catenin activation to drive cell cycle entry

  2015cited by this paper
• Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer.

  2015cited by this paper
• An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell-like Behaviors Contributing to Disease Progression.

  2015cited by this paper
• AMPK modulates Hippo pathway activity to regulate energy homeostasis

  2015influential reference
• A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis

  2015cited by this paper
• Expression of Yes-associated protein (YAP) in metastatic breast cancer.

  2015cited by this paper
• TAZ regulates cell proliferation and epithelial–mesenchymal transition of human hepatocellular carcinoma

  2015cited by this paper
• A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer

  2015cited by this paper
• Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway

  2015influential reference
• Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesis

  2015cited by this paper
• MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway

  2015cited by this paper
• TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells.

  2015cited by this paper
• Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells

  2015cited by this paper
• Ski regulates Hippo and TAZ signaling to suppress breast cancer progression

  2015cited by this paper
• Functional and Clinical Evidence That TAZ is a Candidate Oncogene in Hepatocellular Carcinoma

  2015cited by this paper
• Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis

  2015cited by this paper
• Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state

  2015influential reference
• A gp130–Src–YAP module links inflammation to epithelial regeneration

  2015influential reference
• Alternative Wnt Signaling Activates YAP/TAZ.

  2015influential reference
• YAP enhances the pro‐proliferative transcriptional activity of mutant p53 proteins

  2015cited by this paper
• Microenvironment rigidity modulates responses to the HER2 receptor tyrosine kinase inhibitor lapatinib via YAP and TAZ transcription factors

  2015cited by this paper
• Eradicating tumor drug resistance at its YAP‐biomechanical roots

  2015cited by this paper
• Two-signal requirement for growth-promoting function of Yap in hepatocytes

  2015influential reference
• YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage

  2015cited by this paper
• Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells

  2015cited by this paper
• YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells

  2015cited by this paper
• ADF and Cofilin1 Control Actin Stress Fibers, Nuclear Integrity, and Cell Survival

  2015cited by this paper
• The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

  2015cited by this paper
• ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors.

  2015influential reference
• YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers

  2015influential reference
• Chronic inflammation imposes aberrant cell fate in regenerating epithelia through mechanotransduction

  2015cited by this paper
• β-Catenin destruction complex-independent regulation of Hippo–YAP signaling by APC in intestinal tumorigenesis

  2015influential reference
• The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression

  2015influential reference
• Hippo pathway activity influences liver cell fate.

  2014cited by this paper
• YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients

  2014influential reference
• Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression

  2014influential reference
• Expression and Clinical Significance of YAP, TAZ, and AREG in Hepatocellular Carcinoma

  2014cited by this paper
• A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis

  2014influential reference
• The biology of YAP/TAZ: hippo signaling and beyond.

  2014cited by this paper
• Yes-Associated Protein (YAP) Modulates Oncogenic Features and Radiation Sensitivity in Endometrial Cancer

  2014influential reference
• A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer.

  2014influential reference
• Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP.

  2014influential reference
• Metabolic control of YAP and TAZ by the mevalonate pathway

  2014influential reference
• The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy

  2014cited by this paper
• Expression of Yes-Associated Protein in Cervical Squamous Epithelium Lesions

  2014cited by this paper
• YAP and TAZ regulate skin wound healing.

  2014cited by this paper
• Tumor‐propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis

  2014influential reference
• Plasticity of epithelial stem cells in tissue regeneration

  2014influential reference
• Canonical Wnt signalling activates TAZ through PP1A during osteogenic differentiation

  2014cited by this paper
• Significant Association of Oncogene YAP1 with Poor Prognosis and Cetuximab Resistance in Colorectal Cancer Patients

  2014cited by this paper
• In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival

  2014cited by this paper
• TAZ promotes epithelial to mesenchymal transition via the upregulation of connective tissue growth factor expression in neuroblastoma cells

  2014influential reference
• KRAS and YAP1 converge to regulate EMT and tumor survival.

  2014influential reference
• The conserved misshapen-warts-Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in Drosophila.

  2014cited by this paper
• YAP activation is an early event and a potential therapeutic target in liver cancer development.

  2014cited by this paper
• Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.

  2014cited by this paper
• Angiomotins link F-actin architecture to Hippo pathway signaling

  2014cited by this paper
• SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma

  2014cited by this paper
• Loss of α-catenin elicits a cholestatic response and impairs liver regeneration

  2014cited by this paper
• RESCUE OF HIPPO CO-ACTIVATOR YAP1 TRIGGERS DNA DAMAGE-INDUCED APOPTOSIS IN HEMATOLOGICAL CANCERS

  2014influential reference
• YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response.

  2014influential reference
• TAZ Is Highly Expressed in Gastric Signet Ring Cell Carcinoma

  2014cited by this paper
• The Hippo transducer TAZ interacts with the SWI/SNF complex to regulate breast epithelial lineage commitment.

  2014cited by this paper
• Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas.

  2014cited by this paper
• Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein.

  2014cited by this paper

• Recent advances on Hippo-YAP pathway in skin diseases

  2026cites this paper
• Basroparib inhibits YAP-driven cancers by stabilizing angiomotin.

  2026cites this paper
• YAP1 signalling and cancer: molecular pathways reveal novel targeting opportunities.

  2026cites this paper
• The Extracellular Matrix Regulates Invasion in Fusion-Negative Rhabdomyosarcoma via YAP-PIEZO1 Signaling Axis

  2026cites this paper
• PRIP/PLCL deficiency activates PI3K-AKT-YAP signaling and promotes organ fibrosis.

  2026cites this paper
• Targeting the USP7-PRMT6 epigenetic axis overcomes chemoresistance in breast cancer by coordinating H3R2me2a deposition and RNF168 methylation for DNA repair and ferroptosis blockade.

  2026cites this paper
• Cellular plasticity: a double-edged sword driving malignant transformation and adaptive remodeling in stem cells

  2026cites this paper
• Distinct molecular pathways leading to dosage-dependent temozolomide resistance in GBM stem cells.

  2026cites this paper
• ROS-Driven Rewiring of Hippo-Inflammation-Polycomb Axis by PFOA in 2D and 3D Lung Epithelial Models.

  2026cites this paper
• Molecular Mechanisms of Chondrocyte Hypertrophy Mediated by Physical Cues and Therapeutic Strategies in Osteoarthritis

  2026cites this paper
• YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells

  2026cites this paper
• Piezo1 as a mechanical checkpoint in T cell immunotherapy for solid tumors.

  2026cites this paper
• Mechanistic insights into the evolution from spasmolytic polypeptide-expressing metaplasia to gastric cancer (Review)

  2026cites this paper
• Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.

  2026cites this paper
• LINC00473 modulates protein expression to promote ovarian cancer progression and overcome cisplatin resistance

  2026cites this paper
• Subtype-Dependent Expression Patterns of Core Hippo Pathway Components in Thymic Epithelial Tumors (TETs): An RT-qPCR Study.

  2026cites this paper
• Integrative machine learning identifies a TEAD4-driven endothelial program shaping drug sensitivity and microvascular invasion in HCC.

  2026cites this paper
• Deciphering the signaling landscape of YAP in the tumor microenvironment-Insights into hepatocellular carcinoma progression.

  2026cites this paper
• Restoring the tumour mechanophenotype of vocal fold cancer reverts its malignant properties.

  2026cites this paper
• Inhibition of PRMT5-Dependent YAP Methylation Attenuates Tumorigenicity and Radioresistance in Glioblastoma.

  2026cites this paper
• From fitness to fate: Hippo-YAP-mediated cell competition influence on stem cells activity

  2026cites this paper
• LRRC15 in tumorigenesis, progression, and therapy.

  2026cites this paper
• Hippo signaling as a therapeutic switch for T cell functions and tumor immunity.

  2026cites this paper
• MED12 Dictates Epithelial Ovarian Cancer Cell Ferroptosis Sensitivity via YAP–TEAD1 Signaling

  2026cites this paper
• Key genes and pathway differences between serrated polyps and conventional adenomas: insights from multi-omics

  2026cites this paper
• Impact of mechanical property alterations on cancer cell motility and metastasis.

  2026cites this paper
• Discovery of a potent and orally bioavailable reversible TEAD inhibitor (R)-3-(5-(1-methyl-3-((4-(trifluoromethyl)phenyl)amino)-1H-pyrazol-4-yl)-1,3,4-oxadiazol-2-yl)-3-vinylpyrrolidin-2-one

  2026cites this paper
• Conventional and Novel Approaches to Establishing Mouse Models of Gastric Cancer in the Past, Present, and Potential Post-H. Pylori Infection Era.

  2026cites this paper
• LBPs NPs suppress breast cancer progression by inhibiting YAP1 expression to induce ferroptosis and alter energy metabolism.

  2026cites this paper
• Hippo signalling pathway mediates oncogenic properties of NAB2::STAT6 in solitary fibrous tumour

  2026cites this paper
• Disrupting the Formation of YAP Condensates Promotes the Activation of AMPKα to Inhibit the Progression of Primary Liver Cancer

  2026cites this paper
• Secoemestrin C exerts rapid and prominent anti-breast cancer effect in triple-negative breast cancer by inducing SLX4 and YAP degradation.

  2026cites this paper
• Oncogenic YAP sensitizes cells to CHK1 inhibition via CDK4/6 driven G1 acceleration

  2025cites this paper
• PR55α subunit of protein phosphatase 2A supports KRASG12D-driven tumorigenesis that requires YAP activation

  2025cites this paper
• Agonist- and stress-driven compartmentalized phosphoinositide signaling in cells.

  2025cites this paper
• Analysis of knockout mice reveals critical female-specific roles for the Hippo pathway component PTPN14.

  2025cites this paper
• Exploring hiPSC-CM replacement therapy in ischemic hearts

  2025cites this paper
• YAP as a therapeutic target to reverse trastuzumab resistance

  2025cites this paper
• Unraveling the Hippo pathway: YAP/TAZ as central players in cancer metastasis and drug resistance

  2025cites this paper
• Molecular basis and therapeutic implications of binary YAPOn/YAPOff cancer classes

  2025cites this paper
• CKAP5 promotes progression and cisplatin resistance in esophageal squamous cell carcinoma via microtubule-mediated YAP activation.

  2025cites this paper
• Hippo pathway effectors are associated with glioma patient survival, control cell proliferation and sterol metabolism through TEAD3

  2025cites this paper
• Auranofin resensitizes ferroptosis-resistant lung cancer cells to ferroptosis inducers.

  2025cites this paper
• Targeting the Hippo Pathway in Breast Cancer: A Proteomic Analysis of Yes-Associated Protein Inhibition

  2025cites this paper
• CDK4/6-mediated phosphorylation of DUB3 promotes YAP1 stability and hepatocellular carcinoma progression

  2025cites this paper
• Engineered bone-targeting apoptotic vesicles as a minimally invasive nanotherapy for heterotopic ossification

  2025cites this paper
• Lymphatic Metastasis of Esophageal Squamous Cell Carcinoma: The Role of NRF2 and Therapeutic Strategies

  2025cites this paper
• The cardiac glycoside periplocymarin sensitizes gastric cancer to ferroptosis via the ATP1A1-Src-YAP/TAZ-TFRC axis.

  2025cites this paper
• Dynamic structure and function of nuclear pore protein complex: Potential roles of lipid and lamins regulated nuclear membrane curvature.

  2025cites this paper
• Integration of focal adhesion morphogenesis and polarity by DOCK5 promotes YAP/TAZ-driven drug resistance in TNBC

  2025cites this paper
• YAP/TAZ: An Epitome of Tumorigenesis.

  2025cites this paper
• Application of mass cytometry in the immune microenvironment of breast cancer

  2025cites this paper
• LDHA-mediated YAP lactylation promotes the tumor progression of hepatocellular carcinoma by inducing YAP dephosphorylation and activation

  2025cites this paper
• Extracellular matrix: unlocking new avenues in cancer treatment

  2025cites this paper
• P4HA1 mediates YAP hydroxylation and accelerates collagen synthesis in temozolomide-resistant glioblastoma

  2025cites this paper
• The tumor suppressor FAT1 controls YAP/TAZ protein degradation and tumor cell proliferation through E3 ligase MIB2

  2025cites this paper
• Cancer network pharmacology: multi-network regulatory mechanisms and future directions

  2025cites this paper
• XMU-MP-1, Inhibitor of STE20-like MST1/2 Kinases of the Hippo Signaling Pathway, Suppresses the Cell Cycle, Activates Apoptosis and Autophagy, and Induces Death of Hematopoietic Tumor Cells

  2025cites this paper
• Hippo/YAP signaling pathway in colorectal cancer: regulatory mechanisms and potential drug exploration

  2025cites this paper
• A novel bispecific integrin α5β1/αv antibody reprograms the Myc-regulated basal phenotype of prostate cancer with natural killer cell-mediated tumor elimination.

  2025cites this paper
• STK3 is a transcriptional target of YAP1 and a hub component in the crosstalk between Hippo and Wnt signaling pathways during gastric carcinogenesis

  2025cites this paper
• TEAD-targeting small molecules induce a cofactor switch to regulate the Hippo pathway

  2025cites this paper
• Machine learning-driven programmed cell death signature for prognosis and drug candidate discovery in diffuse large B-cell lymphoma: Multi-cohort study and experimental validation.

  2025cites this paper
• Cell Confluency Affects p53 Dynamics in Response to DNA Damage.

  2025cites this paper
• Phosphoinositide signalling in cell motility and adhesion

  2025cites this paper
• Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer

  2025influential citation
• Glycolysis-related lncRNA FTX upregulates YAP1 to facilitate colorectal cancer progression via sponging miR-215-3p

  2025cites this paper
• NUDT21 Functions as a Pro-Tumorigenic Gene in Colorectal Cancer by Upregulating the TAZ Protein Expression

  2025cites this paper
• SOAT1 exacerbates tumor progression by promoting YAP signaling activation and attenuating endoplasmic reticulum stress

  2025cites this paper
• 靶向YAP/TAZ信号通路改善肿瘤免疫治疗的研究进展

  2025cites this paper
• A YAP-derived peptide blocks YAP-TEAD signaling and suppresses cell proliferation.

  2025cites this paper
• Integrative research on the mechanisms of acupuncture mechanics and interdisciplinary innovation

  2025cites this paper
• A skin organoid-based infection platform identifies an inhibitor specific for HFMD

  2025cites this paper
• 8q24 derived ZNF252P promotes tumorigenesis by driving phase separation to activate c-Myc mediated feedback loop

  2025cites this paper
• Piezo1-related physiological and pathological processes in glioblastoma

  2025cites this paper
• Discovery and biological evaluation of carborane-containing derivatives as TEAD auto palmitoylation inhibitors.

  2025cites this paper
• Decoding chromosomal instability insights in CRC by integrating omics and patient-derived organoids

  2025cites this paper
• Dual Inhibition of IRE1α and YAP Signaling as a Potential Therapy for Epithelial Ovarian Carcinoma.

  2025cites this paper
• Hyperactivated YAP1 is essential for sustainable progression of renal clear cell carcinoma

  2025cites this paper
• Antitumor potential of polyamines in cancer

  2025cites this paper
• The IGF2BP1 oncogene is a druggable m6A-dependent enhancer of YAP1-driven gene expression in ovarian cancer

  2025cites this paper
• HDAC inhibitors modulate Hippo pathway signaling in hormone positive breast cancer

  2025cites this paper
• Ultraviolet B Exposure Does Not Influence the Expression of YAP mRNA in Human Epidermal Keratinocytes—Preliminary Study

  2025cites this paper
• Gracillin suppresses cancer progression through inducing Merlin/LATS protein-protein interaction and activating Hippo signaling pathway

  2025cites this paper
• Microbial metabolites control self-renewal and precancerous progression of human cervical stem cells

  2025cites this paper
• The Role of Yes‐Associated Protein in Inflammatory Diseases and Cancer

  2025cites this paper
• Mechanism of Lung Fibrosis Caused by Rare Earth Samarium Oxide Through Hippo Signaling Pathway and the Intervention of GBE

  2025cites this paper
• Hyper-responsiveness of cancer stem cells to microenvironmental cues controls metastasis and therapy response through YAP/TAZ/TEAD

  2025influential citation
• Elevated VRK1 levels after androgen deprivation therapy promote prostate cancer progression by upregulating YAP1 expression

  2025cites this paper
• The Role of Connections Between Cellular and Tissue Mechanical Elements and the Importance of Applied Energy in Mechanotransduction in Cancerous Tissue

  2025cites this paper
• PDLIM3 Regulates Migration and Invasion of Head and Neck Squamous Cell Carcinoma via YAP–Mediated Epithelial–Mesenchymal Transition

  2025cites this paper
• A novel clinically relevant antagonistic interplay between prolactin and oncogenic YAP-CCN2 pathways as a differentiation therapeutic target in breast cancer

  2025cites this paper
• Peptide-Modified Lipid Nanoparticles Boost the Antitumor Efficacy of RNA Therapeutics

  2025cites this paper
• “Putting the cart before the horse”: an update on promiscuous gene fusions in soft tissue tumors

  2025cites this paper
• Celastrol loaded nanocomplex for painless tumor therapy via YAP inhibition

  2025cites this paper
• Mechanisms of bone regeneration repair and potential and efficacy of small molecule drugs.

  2025cites this paper
• Long non-coding RNA LRTOR drives osimertinib resistance in non-small cell lung cancer by boosting YAP positive feedback loop.

  2025cites this paper
• The mechanism of YAP/TAZ transactivation and dual targeting for cancer therapy

  2025cites this paper
• Novel hydrogel-based cancer-on-a-chip models for growth of 3D multi-cellular structures and investigation of early angiogenesis in pancreatic ductal adenocarcinoma.

  2025cites this paper
• Unveiling the potential of biomechanics in pioneering innovative strategies for cancer therapy

  2025cites this paper